Haem: Myelodysplastic syndromes and Aplastic anaemia Pt.1 Flashcards

1
Q

Define myelodysplastic syndrome.

A

Biologically heterogenous group of acquired haematological stem cell disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the key characteristics of myelodysplastic syndromes?

A

Development of a clone of marrow stem cell with abnormal maturation resulting in

  • Functionally defective blood cells
  • Numerial reduction in cell counts

This leads to
1. Cytopaenia
2. Functional abnormalities of erythroid, myeloid, and megakaryocyte maturation
3. Increased risk of transformation to leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which types of patients tend to develop myelodysplastic syndromes?

A

Elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do myelodysplastic syndromes typically present?

A

Symptoms/signs of bone marrow failure developing over weeks/months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List and describe some blood and bone marrow features of myelodysplastic syndromes - seen on blood film

A
  • Pelger-Huet anomaly - bilobed neutrophils
  • Dysgranulopoeisis of neutrophils - failure of granulation
  • Dyserythropoiesis of red blood cells -lack of separation between red cell precursors (cytoplasmic bridge), presence of abnormal ring of cytoplasm around the nucleus of percursor red cells
  • Dysplastic megakaryocytes - micro-megakaryocytes
  • Increased proportion of blast cells in the bone marrow (normally < 5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does this image show?

A

Pelger-Huet anomaly
Nucleus appears bilobed or dumb-bell shaped

Normal neutrophils shown below

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does this image show?

A

Refractory anaemia with dysgranulopoiesis - failure of neutrophil granulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does this image show?

A

Refractory anaemia-dyserythropoiesis
- Lack of separation between red cell precursors
- Presence of abnormal blebby ring of cytoplasm around the nucleus of precursor red cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does this image show?
Name the stain used

A

Ringed sideroblasts
- Accumulation of iron around the nuclei of red blood cell precursors
- Seen in refractory anaemia with ringed sideroblasts (RARS)

Seen on Prussian blue stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the presence of myeloblasts with Auer rods suggestive of?

A

Acute myeloid leukaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List the criteria of the WHO classification of MDS

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the five prognostic variables that are used to calculate prognostic risk using the Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes?

A

The high risk is considered a score > 6, low risk ≤ 1.5
The higher the risk, the lower the survival and time to progress to AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does myelodysplasia tend to evolve from the time of diagnosis?

A
  • Blood count deterioration - leads to worsening bone marrow failure)
  • Development of acute myeloid leukaemia - extremely poor prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the usual causes of death in patients with myelodysplasia?

A
  • 1/3 infection
  • 1/3 bleeding
  • 1/3 leukaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the two treatments that can prolong life in myelodysplastic syndromes?

A
  • Allogeneic stem cell transplantation
  • Intensive chemotherapy

NOTE: as most MDS patients are elderly, they often cannot tolerate treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List some other treatments that may be used in myelodysplastic syndromes.

A

Supportive Care

  • Blood products support
  • Antimicrobials
  • Growth factors e.g. EPO, G-CSF, TPO-agonist (eltrombopag)

Biological modifiers - treating underlying disease

  • Immunosuppression
  • Azacytidine or Decitabine (hypomethylating agent)
  • Lenalidomide (used in del(5q) minus syndrome)

Oral chemotherapy (e.g. hydroxyurea) - if WCC is high (less common)

Low-dose chemotherapy (SC low-dose cytarabine) - not used now

17
Q

What is bone marrow failure a result of?

A

Results from damage or suppression of stem or progenitor cells

  • Damage to pluripotent stem cell - impairs production of ALL peripheral blood cells
  • Damage to committed progenitor cells - results in bi- or unicytopenias
18
Q

List some primary and secondary causes of bone marrow failure

A
19
Q

List some causes of primary aplastic anaemia

A

Acquired: idiopathic aplastic anaemia (MOST COMMON - 70-80%)

Congential (RARE):

  • Fanconi anaemia (multipotent stem cell)
  • Dyskeratosis congentia
20
Q

List some secondary causes of aplastic anaemia

A
  • Radiation
  • Drugs - cytotoxic drugs (predicable), chloramphenicol, NSAIDS (both idosyncratic)
  • Autoimmune - SLE
  • Infection - parvovirus B19, hepatitis, HIV
21
Q

List some drugs that can cause bone marrow failure.

A
  • Cytotoxic drugs (predicatble, dose-dependent)
  • Phenylbutazone, Gold salts (idiosyncratic, rare)
  • Antibiotics - chloramphenicol, sulphonamides
  • Diuretics - thiazide
  • Antithyroid drugs - carbimazole
22
Q

What is aplastic anaemia

A

Hypocellular anaemia

(cytopenia without tumour etc in bone marrow)

23
Q

Which age groups are affected by aplastic anaemia?

A

All age groups can be affected - mainly 15-24 and 60+

NOTE: this is much more rare than MDS

24
Q

What is the most common cause of aplastic anaemia?

A

Idiopathic (70-80%)